Skip to content
LexBuild

Medical Devices; Reclassification of the Topical Oxygen Chamber for Extremities; Correction

---
identifier: "/us/fr/2011-12410"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Medical Devices; Reclassification of the Topical Oxygen Chamber for Extremities; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2011-12410"
section_name: "Medical Devices; Reclassification of the Topical Oxygen Chamber for Extremities; Correction"
positive_law: false
currency: "2011-05-20"
last_updated: "2011-05-20"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2011-12410"
document_type: "rule"
publication_date: "2011-05-20"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 878"
fr_citation: "76 FR 29153"
fr_volume: 76
docket_ids:
  - "Docket No. FDA-2006-N-0045"
  - "Formerly Docket No. 2006N-0109"
effective_date: "2011-05-25"
fr_action: "Final rule; correction."
---

#  Medical Devices; Reclassification of the Topical Oxygen Chamber for Extremities; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Final rule; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the *Federal Register* of April 25, 2011 (76 FR 22805). The document announced that FDA is reclassifying the topical oxygen chamber for extremities (TOCE) from class III to class II. The document published inadvertently used outdated contact information. This document corrects that error.

**DATES:**

Effective May 25, 2011.

**FOR FURTHER INFORMATION CONTACT:**

Charles N. Durfor, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. G424, Silver Spring, MD 20993-0002, 301-796-6438.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 2011-9899 appearing on page 22805 in the *Federal Register* of Monday, April 25, 2011, the following correction is made: 1. On page 22805, in the third column, the *FOR FURTHER INFORMATION CONTACT* section is corrected to read as follows:

*FOR FURTHER INFORMATION CONTACT:* Charles N. Durfor, Center for Devices and Radiological Health, Food and Drug Administration, Bldg. 66, Rm. G424, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-6438.

Dated: May 17, 2011.

Nancy K. Stade,

Deputy Director for Policy, Center for Devices and Radiological Health.